Primary packaging
The lyophilized powder containing 20 mg of the active ingredient is placed in a colorless glass type 3 bottle sealed with a bromobutyl rubber stopper, crimped with an aluminum ring or an aluminum cap "flip off" with plastic disc or plastic lid, over aluminum.
Solvent (water for injection): 2 ml per ampoule of colorless glass. Secondary packaging:
1 bottle with the drug and 1 ampoule with the solvent is placed in a cassette made of polyvinyl chloride; 1 cassette along with the instructions for use are placed in a cardboard box.
1 bottle with the drug and 1 ampoule with a solvent, along with instructions for use, are placed in a cardboard box.
50 bottles of the drug are placed in a cardboard box (for hospitals): with instructions for use; 50 ampoules of solvent are placed in a separate cardboard box (for hospitals).